Synthesis and evaluation of 18F labeled FET prodrugs for tumor imaging

被引:14
作者
Wang, Limin [1 ]
Lieberman, Brian P. [1 ]
Ploessl, Karl [1 ]
Kung, Hank F. [1 ,2 ]
机构
[1] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
F-18; FET; PET; Peptide; Prodrug; Imaging agent; POSITRON-EMISSION-TOMOGRAPHY; AMINO-ACID; GLIAL METABOLISM; BRAIN-TUMORS; BIOLOGICAL EVALUATION; CEREBRAL GLIOMAS; RAT-BRAIN; PET; TRANSPORTERS; EXPRESSION;
D O I
10.1016/j.nucmedbio.2013.09.011
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Introduction: O-(2-[F-18]fluoroethyl)-l-tyrosine (FET, [18F]1) is a useful amino-acid-based imaging agent for brain tumors. This paper reports the synthesis and evaluation of three FET prodrugs, O-(2-[F-18]fluoroethyl)-l-tyrosyl-l-glycine (FET-Gly, [F-18]2), O-(2-[F-18]fluoroethyl)-l-tyrosyl-l-alanine (FET-Ala, [F-18]3) and N-acetyl O-(2-[F-18]fluoroethyl)-l-tyrosine (AcFET, [F-18]4), which could be readily hydrolyzed to FET in vivo for tumor imaging. We investigated their metabolism in the blood and imaging properties in comparison to FET ([F-18]1). Methods: Three new [F-18]FET derivatives, 24, were prepared from their corresponding tosylate-precursors through nucleophilic fluorination and subsequent deprotection reactions. In vitro uptake studies were carried out in 9L glioma cancer cell lines. In vitro and in vivo hydrolysis studies were conducted to evaluate the hydrolysis of FET prodrugs in blood and in Fisher 344 rats. Biodistribution and PET imaging studies were then performed in rats bearing 9L tumors. Results: New FET prodrugs were prepared with 328% decay corrected radiochemical yields, good enantiomeric purity (> 95%) and high radiochemical purity (> 95%). FET-Gly ([F-18]2), FET-Ala ([F-18]3), and AcFET ([F-18]4) exhibited negligible uptake in comparison to the high uptake of FET ([F-18]1) in 9L cells. Metabolism studies of FET-Gly ([F-18]2), FET-Ala ([F-18]3), and AcFET ([F-18]4) in rat and human blood showed that FET-Ala ([F-18]3) was hydrolyzed to FET ([F-18]1) faster than FET-Gly ([F-18]2) or AcFET ([F-18]4). Most of the FET-Ala (79%) was converted to FET ([F-18]1) within 5 min in blood in vivo. Biodistribution studies demonstrated that FET-Ala ([F-18]3) displayed the highest tumor uptake. The tumor-to-background ratios of FET-Ala ([F-18]3) and FET ([F-18]1) were comparable and appeared to be better than those of FET-Gly ([F-18]2) and AcFET ([F-18]4). PET imaging studies showed that both FET ([F-18]1) and FET-Ala ([F-18]3) could visualize tumors effectively, and that they share similar imaging characteristics. Conclusions: FET-Ala ([F-18]3) demonstrated promising properties as a prodrug of FET ([F-18]1), which could be used in PET imaging of tumor amino acid metabolism. (C) 2014 Elsevier Inc. All rights reserved.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 40 条
[1]   INFLUENCE OF MOLECULAR-STRUCTURE ON HALF-LIFE AND HYDROLYSIS OF DIPEPTIDES IN PLASMA - IMPORTANCE OF GLYCINE AS N-TERMINAL AMINO-ACID RESIDUE [J].
ADIBI, SA ;
PALEOS, GA ;
MORSE, EL .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1986, 35 (09) :830-836
[2]   Cyclic peptides containing a δ-sugar amino acid-synthesis and evaluation as artificial receptors [J].
Billing, JF ;
Nilsson, UJ .
TETRAHEDRON, 2005, 61 (04) :863-874
[3]   Two-colour screening in combinatorial chemistry: prospecting for enantioselectivity in a library of steroid-based receptors [J].
del Amo, Vicente ;
McGlone, Adam P. ;
Soriano, Jose M. ;
Davis, Anthony P. .
TETRAHEDRON, 2009, 65 (32) :6370-6381
[4]  
Ganapathy V, 2008, PHARM THERA
[5]   Design, synthesis, and preliminary pharmacological evaluation of new imidazolinones as L-DOPA prodrugs [J].
Giorgioni, Gianfabio ;
Claudi, Francesco ;
Ruggieri, Sabrina ;
Ricciutelli, Massimo ;
Palmieri, Giovanni F. ;
Di Stefano, Antonio ;
Sozio, Piera ;
Cerasa, Laura S. ;
Chiavaroli, Annalisa ;
Ferrante, Claudio ;
Orlando, Giustino ;
Glennon, Richard A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (05) :1834-1843
[6]   FDG UPTAKE, TUMOR PROLIFERATION AND EXPRESSION OF GLYCOLYSIS ASSOCIATED GENES IN ANIMAL TUMOR-MODELS [J].
HABERKORN, U ;
ZIEGLER, SI ;
OBERDORFER, F ;
TROJAN, H ;
HAAG, D ;
PESCHKE, P ;
BERGER, MR ;
ALTMANN, A ;
VANKAICK, G .
NUCLEAR MEDICINE AND BIOLOGY, 1994, 21 (06) :827-834
[7]   Efficient routine production of the 18F-labelled amino acid O-(2-[18F]fluoroethyl)-L-tyrosine [J].
Hamacher, K ;
Coenen, HH .
APPLIED RADIATION AND ISOTOPES, 2002, 57 (06) :853-856
[8]   Multimodality Assessment of Brain Tumors and Tumor Recurrence [J].
Heiss, Wolf-Dieter ;
Raab, Peter ;
Lanfermann, Heinrich .
JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (10) :1585-1600
[9]   Current perspectives on established and putative mammalian oligopeptide transporters [J].
Herrera-Ruiz, D ;
Knipp, GT .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (04) :691-714
[10]   Evaluation of [14C]phenylacetate as a prototype tracer for the measurement of glial metabolism in the rat brain [J].
Inoue, Osamu ;
Hosoi, Rie ;
Momosaki, Sotaro ;
Yamamoto, Keisuke ;
Amitani, Misato ;
Yamaguchi, Masatoshi ;
Gee, Antony .
NUCLEAR MEDICINE AND BIOLOGY, 2006, 33 (08) :985-989